BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

1. Yeah, but they're not basing the available US market on...

  1. 1,843 Posts.
    lightbulb Created with Sketch. 1231

    1. Yeah, but they're not basing the available US market on number of scripts sold in Japan. Apples and oranges. Available US market is what it is.
    2. I agree EH are being very, very modest. But also remember that Japan sells scripts for $70, not $700. The cost of living there is NOT 10 times cheaper than the US. Also, Japanese have 4 times the prevalence for AH. So I can't imagine the same direct correlation of Japan v US.

    But still, I do think the EH is overly conservative and I do think the market is missing the mark. I think offers starting with $ signs will be very reasonable soon.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.